The Molecular Biology Society of Japan

[2P-0516] In silico drug screening by using genome-wide association study (GWAS)-data repurposed a novel disease-modifying drug for Parkinson’s disease

〇TAKESHI UENAKA1, WATARU SATAKE1, Pei-Chieng Cha1, HIDEKI HAYAKAWA2, KOUSUKE BABA2, SHIYING JIANG2, KAZUHIRO KOBAYASHI1, MOTOI KANAGAWA1, YUKINORI OKADA3,4, HIDEKI MOCHIZUKI2, TATSUSHI TODA5,1 (1.Div of Neurol/Mol Brain Sci, Kobe Univ Graduate School of Med, 2.Dep of Neurol, Osaka Univ Graduate School of Med, 3.Dep of Statistical Genetics, Osaka Univ Graduate School of Med, 4.Lab of Statistical Immunol, Immunol Frontier Research Center (WPI-IFReC), Osaka Univ, 5.Dep of Neurol, Graduate School of Med, The Univ of Tokyo)

Parkinson's disease, drug repurposing, genome-wide association study

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password